Dr. Xi Chen

Implementation of procedures for clinical evaluation, writer and reviewer of clinical evaluation reports, according to Medical Device Regulation (EU) 2017/745 (MDR), the guideline MEDDEV 2.7/1, 4th edition and current MDCG guidelines. Author and reviewer of clinical evaluation reports according to CFDA/NMPA Announcement 2015 No.14 (China). Supporting clinically relevant PMS and other technical documentation activities.

Implementation of procedures for clinical evaluation according to the Medical Device Directive 93/42/EEC (MDD), Medical Device Regulation (EU) 2017/745 (MDR) and the guideline MEDDEV 2.7/1, 4th edition. Author and reviewer of clinical evaluation reports for products of all risk classes according to MEDDEV 2.7/1, Medical Device Directive 93/42/EEC, and CFDA/NMPA Announcement 2015 No.14 (China). Business Development in the Chinese Market

It focused on discovering the candidate genes involved in resistance against an endophytic microbe.

Producing knockout mutants using CRISPR-Cas9 system; Japanese language learning.

Dissertation Topic: “Approaches towards detection of candidate genes in Oryza sativa involved in endophytic colonization of Azoarcus sp. strain BH72” (1.3/ very good/magna cum laude)

Thesis: “Detecting candidate genes in Oryza sativa involved in endophytic colonization with microarray“ (1.3/very good) Course Highlights: Advanced molecular biology in plant biology, Microbiology and cell biology, Protein analysis, Organic chemistry, Advanced practical training in microbiology.

Bachelor thesis: “16s rDNA sequences analysis” (1.0/ very good). Course highlights: General biology education, with an emphasis on molecular biology.